Award

NHS Framework Agreement for the supply of Adult Influenza Vaccines - Secondary Care

THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)

This public procurement record has 2 releases in its history.

Award

08 Sep 2021 at 14:50

Tender

27 Apr 2021 at 12:03

Summary of the contracting process

The NHS Commissioning Board (operating under the name of NHS England) has initiated a framework agreement for the supply of Adult Influenza Vaccines for Secondary Care, which commenced on 1 September 2021 and is set to run for a period of 12 months, with options for extensions up to a total maximum of 48 months. This procurement, classified under the CPV code 33651660, pertains to the goods category specifically targeting the healthcare industry. Key deadlines include the tendering period, which closed on 2 June 2021, with the award likely following the bid opening date on the same day in Runcorn, UK.

This opportunity presents significant growth potential for businesses within the pharmaceutical and healthcare sectors, particularly manufacturers and suppliers of vaccines. Companies that excel in quality assurance, supply chain management, and offer competitive pricing are well-suited to compete for this contract. Moreover, participation in this framework can enable businesses to establish long-term relationships with NHS entities and contribute to public health initiatives, fostering both profitability and social responsibility.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

NHS Framework Agreement for the supply of Adult Influenza Vaccines - Secondary Care

Notice Description

NHS Framework Agreement for the supply of Adult Influenza Vaccines - Secondary Care. Period of framework agreement: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months . Please refer to the invitation to offer documents for a list of the purchasing points.

Lot Information

Lot 1 - aQIV

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

Options: option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months.

Lot 2 - QIV-HD

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

Options: option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months.

Lot 3 - QIVc

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

Options: option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months.

Renewal: The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months.

Lot 4 - QIVr

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

Options: option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months.

Lot 5 - QIVe

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

Options: option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-02aa9d
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/022304-2021
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33651660 - Influenza vaccines

Notice Value(s)

Tender Value
£29,200,000 £10M-£100M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
8 Sep 20214 years ago
Submission Deadline
2 Jun 2021Expired
Future Notice Date
Not specified
Award Date
17 Aug 20214 years ago
Contract Period
31 Aug 2021 - 31 Aug 2022 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active, Unsuccessful
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)
Contact Name
Philip Grieve
Contact Email
philip.grieve@nhs.net
Contact Phone
Not specified

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Post Town
Warrington
Country
England

Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
Not specified

Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
2
Supplier Names

AVENTIS PHARMA LTD T/A SANOFI

SEQIRUS

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-02aa9d-2021-09-08T15:50:13+01:00",
    "date": "2021-09-08T15:50:13+01:00",
    "ocid": "ocds-h6vhtk-02aa9d",
    "description": "RESPONDING TO THIS NOTICE:Any supplier may be disqualified who does not respond to the following in the requisite manner:1) Submission of expression of interest and procurement specific informationThis procurement exercise will be conductedon the eTendering portal athttps://healthfamily.force.com/s/WelcomeCandidates wishing to be considered for this procurement exercise must register, and provide additional procurement specificinformation (if requested) through the eTendering portal as follows:1.1) If not already registered, Candidates should register on the eTendering portal athttps://health-family.force.com/s/Welcome andclick the link to register:- agree to the user agreement- populate company details1.2) Once registered, candidates must register interest as follows:- log to the portal- select \"Find Opportunities\" from the supplier home screen, use the \"Sort by:\" facility to find this opportunity and select the bold blue titleto select- review opportunity details and click \"Register Interest\"- as you select the opportunity, you can review documents, send clarification messages, submit the response or decline to respond (ifyou decide not to participate in the opportunity)1.3) There is a supplier user guide on using the system and Candidates can contact the Atamis helpdesk at supporthealth@atamis.co.uk or by calling 0800 9956035 for technical assistance whencompleting responses.2) General supplier information.To manage and assess supplier information the Contracting Authority requests candidates provide their company profile in the Government's Supplier Registration Service (which has replacedsid4gov), as follows:2.1) If not already registered (the previous sid4gov password, login and details will still be on the system), candidates must go to thefollowing web pagehttps://supplierregistration.cabinetoffice.gov.uk and select \"Register\" at the top of the page. Key in details as requested to search for yourcompany. If you do not have a D-U-N-S(r)Number, click on the link at the right of the page to obtain a number from D&B.Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S(r) Number to enable registration on the system.2.2) Once registration is complete you are able to create and update your company profile. Candidates should ensure all the mandatory fields of their profile are completed and up to date for each procurement exercise.D&B data will be supplied automatically by D&B.2.3) For further help or information concerning this telephone +44 (0) 161 413 7982 or via the message function on the website.OTHER CONTRACTING AUTHORITIESThe framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or togetheras members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services orgoods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcareor health related services.",
    "initiationType": "tender",
    "tender": {
        "id": "CM/PHS/20/5623",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "NHS Framework Agreement for the supply of Adult Influenza Vaccines - Secondary Care",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "33651660",
            "description": "Influenza vaccines"
        },
        "mainProcurementCategory": "goods",
        "description": "NHS Framework Agreement for the supply of Adult Influenza Vaccines - Secondary Care. Period of framework agreement: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months . Please refer to the invitation to offer documents for a list of the purchasing points.",
        "value": {
            "amount": 29200000,
            "currency": "GBP"
        },
        "lots": [
            {
                "id": "1",
                "title": "Lot 1 - aQIV",
                "description": "NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points",
                "contractPeriod": {
                    "startDate": "2021-09-01T00:00:00+01:00",
                    "endDate": "2022-08-31T23:59:59+01:00"
                },
                "hasRenewal": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "hasOptions": true,
                "options": {
                    "description": "option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months."
                },
                "status": "cancelled",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Security of Supply",
                            "type": "quality",
                            "description": "10%"
                        },
                        {
                            "name": "Ease of Use",
                            "type": "quality",
                            "description": "3%"
                        },
                        {
                            "type": "price",
                            "description": "87%"
                        }
                    ]
                }
            },
            {
                "id": "2",
                "title": "Lot 2 - QIV-HD",
                "description": "NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points",
                "contractPeriod": {
                    "startDate": "2021-09-01T00:00:00+01:00",
                    "endDate": "2022-08-31T23:59:59+01:00"
                },
                "hasRenewal": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "hasOptions": true,
                "options": {
                    "description": "option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months."
                },
                "status": "cancelled",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Security of Supply",
                            "type": "quality",
                            "description": "10%"
                        },
                        {
                            "name": "Ease of Use",
                            "type": "quality",
                            "description": "3%"
                        },
                        {
                            "type": "price",
                            "description": "87%"
                        }
                    ]
                }
            },
            {
                "id": "3",
                "title": "Lot 3 - QIVc",
                "description": "NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points",
                "contractPeriod": {
                    "startDate": "2021-09-01T00:00:00+01:00",
                    "endDate": "2022-08-31T23:59:59+01:00"
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months."
                },
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "hasOptions": true,
                "options": {
                    "description": "option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months."
                },
                "status": "cancelled",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Security of Supply",
                            "type": "quality",
                            "description": "10%"
                        },
                        {
                            "name": "Ease of Use",
                            "type": "quality",
                            "description": "3%"
                        },
                        {
                            "type": "price",
                            "description": "87%"
                        }
                    ]
                }
            },
            {
                "id": "4",
                "title": "Lot 4 - QIVr",
                "description": "NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points",
                "contractPeriod": {
                    "startDate": "2021-09-01T00:00:00+01:00",
                    "endDate": "2022-08-31T23:59:59+01:00"
                },
                "hasRenewal": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "hasOptions": true,
                "options": {
                    "description": "option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months."
                },
                "status": "cancelled",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Security of Supply",
                            "type": "quality",
                            "description": "10%"
                        },
                        {
                            "name": "Ease of Use",
                            "type": "quality",
                            "description": "3%"
                        },
                        {
                            "type": "price",
                            "description": "87%"
                        }
                    ]
                }
            },
            {
                "id": "5",
                "title": "Lot 5 - QIVe",
                "description": "NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points",
                "contractPeriod": {
                    "startDate": "2021-09-01T00:00:00+01:00",
                    "endDate": "2022-08-31T23:59:59+01:00"
                },
                "hasRenewal": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "hasOptions": true,
                "options": {
                    "description": "option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months."
                },
                "status": "cancelled",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Security of Supply",
                            "type": "quality",
                            "description": "10%"
                        },
                        {
                            "name": "Ease of Use",
                            "type": "quality",
                            "description": "3%"
                        },
                        {
                            "type": "price",
                            "description": "87%"
                        }
                    ]
                }
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33651660",
                        "description": "Influenza vaccines"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    },
                    {
                        "region": "UK"
                    }
                ],
                "deliveryLocation": {
                    "description": "Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)"
                },
                "relatedLot": "1"
            },
            {
                "id": "2",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33651660",
                        "description": "Influenza vaccines"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    },
                    {
                        "region": "UK"
                    }
                ],
                "deliveryLocation": {
                    "description": "Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)"
                },
                "relatedLot": "2"
            },
            {
                "id": "3",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33651660",
                        "description": "Influenza vaccines"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    },
                    {
                        "region": "UK"
                    }
                ],
                "deliveryLocation": {
                    "description": "Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)"
                },
                "relatedLot": "3"
            },
            {
                "id": "4",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33651660",
                        "description": "Influenza vaccines"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    },
                    {
                        "region": "UK"
                    }
                ],
                "deliveryLocation": {
                    "description": "Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)"
                },
                "relatedLot": "4"
            },
            {
                "id": "5",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33651660",
                        "description": "Influenza vaccines"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    },
                    {
                        "region": "UK"
                    }
                ],
                "deliveryLocation": {
                    "description": "Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)"
                },
                "relatedLot": "5"
            }
        ],
        "submissionMethod": [
            "electronicSubmission",
            "written"
        ],
        "submissionMethodDetails": "http://health.atamis.co.uk",
        "communication": {
            "atypicalToolUrl": "http://health.atamis.co.uk"
        },
        "documents": [
            {
                "id": "economic",
                "documentType": "economicSelectionCriteria"
            },
            {
                "id": "technical",
                "documentType": "technicalSelectionCriteria"
            }
        ],
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "techniques": {
            "hasFrameworkAgreement": true
        },
        "coveredBy": [
            "GPA"
        ],
        "tenderPeriod": {
            "endDate": "2021-06-02T13:00:00+01:00"
        },
        "submissionTerms": {
            "languages": [
                "en"
            ],
            "bidValidityPeriod": {
                "endDate": "2021-08-31T23:59:59+01:00"
            }
        },
        "awardPeriod": {
            "startDate": "2021-06-02T13:00:00+01:00"
        },
        "bidOpening": {
            "date": "2021-06-02T13:00:00+01:00",
            "address": {
                "streetAddress": "Runcorn"
            },
            "description": "Commercial Medicines Unit Employee"
        },
        "hasRecurrence": false,
        "contractTerms": {
            "hasElectronicOrdering": true,
            "electronicInvoicingPolicy": "allowed",
            "hasElectronicPayment": true
        }
    },
    "parties": [
        {
            "id": "GB-FTS-2505",
            "name": "The NHS Commissioning Board (operating under the name of NHS England)",
            "identifier": {
                "legalName": "The NHS Commissioning Board (operating under the name of NHS England)"
            },
            "address": {
                "streetAddress": "2nd Floor, Rutland House",
                "locality": "Runcorn",
                "region": "UK",
                "postalCode": "WA7 2ES",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Philip Grieve",
                "email": "philip.grieve@nhs.net",
                "url": "http://health.atamis.co.uk"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody"
            ],
            "details": {
                "url": "https://www.england.nhs.uk/",
                "buyerProfile": "https://www.england.nhs.uk/",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "MINISTRY",
                        "description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-497",
            "name": "The High Court",
            "identifier": {
                "legalName": "The High Court"
            },
            "address": {
                "streetAddress": "Strand",
                "locality": "London",
                "postalCode": "WC2A 2LL",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "generaloffice@administrativecourtoffice.justice.gov.uk"
            },
            "roles": [
                "reviewBody"
            ],
            "details": {
                "url": "https://www.gov.uk/courts-tribunals"
            }
        },
        {
            "id": "GB-FTS-27864",
            "name": "Seqirus UK Limited",
            "identifier": {
                "legalName": "Seqirus UK Limited"
            },
            "address": {
                "streetAddress": "Point, 29 Market Street",
                "locality": "Maidenhead",
                "region": "UK",
                "postalCode": "SL6 8AA",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-27865",
            "name": "Aventis Pharma ltd t/a Sanofi",
            "identifier": {
                "legalName": "Aventis Pharma ltd t/a Sanofi"
            },
            "address": {
                "streetAddress": "410 Thames Valley, Park Drive, Reading",
                "locality": "Reading",
                "region": "UK",
                "postalCode": "RG6 1PT",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-2505",
        "name": "The NHS Commissioning Board (operating under the name of NHS England)"
    },
    "language": "en",
    "awards": [
        {
            "id": "022304-2021-CM/PHS/20/5623-1",
            "relatedLots": [
                "1"
            ],
            "title": "aQIV",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-27864",
                    "name": "Seqirus UK Limited"
                }
            ]
        },
        {
            "id": "022304-2021-CM/PHS/20/5623-2",
            "relatedLots": [
                "3"
            ],
            "title": "QIVc",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-27864",
                    "name": "Seqirus UK Limited"
                }
            ]
        },
        {
            "id": "022304-2021-CM/PHS/20/5623-3",
            "relatedLots": [
                "4"
            ],
            "title": "QIVr",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-27865",
                    "name": "Aventis Pharma ltd t/a Sanofi"
                }
            ]
        },
        {
            "id": "022304-2021-CM/PHS/20/5623-4",
            "relatedLots": [
                "5"
            ],
            "title": "QIVe",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-27865",
                    "name": "Aventis Pharma ltd t/a Sanofi"
                }
            ]
        },
        {
            "id": "022304-2021-5",
            "status": "unsuccessful",
            "statusDetails": "unsuccessful"
        }
    ],
    "contracts": [
        {
            "id": "022304-2021-CM/PHS/20/5623-1",
            "awardID": "022304-2021-CM/PHS/20/5623-1",
            "title": "aQIV",
            "status": "active",
            "dateSigned": "2021-08-18T00:00:00+01:00"
        },
        {
            "id": "022304-2021-CM/PHS/20/5623-2",
            "awardID": "022304-2021-CM/PHS/20/5623-2",
            "title": "QIVc",
            "status": "active",
            "dateSigned": "2021-08-18T00:00:00+01:00"
        },
        {
            "id": "022304-2021-CM/PHS/20/5623-3",
            "awardID": "022304-2021-CM/PHS/20/5623-3",
            "title": "QIVr",
            "status": "active",
            "dateSigned": "2021-08-18T00:00:00+01:00"
        },
        {
            "id": "022304-2021-CM/PHS/20/5623-4",
            "awardID": "022304-2021-CM/PHS/20/5623-4",
            "title": "QIVe",
            "status": "active",
            "dateSigned": "2021-08-18T00:00:00+01:00"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "3",
                "measure": "bids",
                "relatedLot": "1",
                "value": 2
            },
            {
                "id": "10",
                "measure": "bids",
                "relatedLot": "3",
                "value": 2
            },
            {
                "id": "17",
                "measure": "bids",
                "relatedLot": "4",
                "value": 2
            },
            {
                "id": "24",
                "measure": "bids",
                "relatedLot": "5",
                "value": 2
            },
            {
                "id": "4",
                "measure": "smeBids",
                "relatedLot": "1",
                "value": 0
            },
            {
                "id": "11",
                "measure": "smeBids",
                "relatedLot": "3",
                "value": 0
            },
            {
                "id": "18",
                "measure": "smeBids",
                "relatedLot": "4",
                "value": 0
            },
            {
                "id": "25",
                "measure": "smeBids",
                "relatedLot": "5",
                "value": 0
            },
            {
                "id": "5",
                "measure": "foreignBidsFromEU",
                "relatedLot": "1",
                "value": 2
            },
            {
                "id": "12",
                "measure": "foreignBidsFromEU",
                "relatedLot": "3",
                "value": 2
            },
            {
                "id": "19",
                "measure": "foreignBidsFromEU",
                "relatedLot": "4",
                "value": 2
            },
            {
                "id": "26",
                "measure": "foreignBidsFromEU",
                "relatedLot": "5",
                "value": 2
            },
            {
                "id": "6",
                "measure": "foreignBidsFromNonEU",
                "relatedLot": "1",
                "value": 0
            },
            {
                "id": "13",
                "measure": "foreignBidsFromNonEU",
                "relatedLot": "3",
                "value": 0
            },
            {
                "id": "20",
                "measure": "foreignBidsFromNonEU",
                "relatedLot": "4",
                "value": 0
            },
            {
                "id": "27",
                "measure": "foreignBidsFromNonEU",
                "relatedLot": "5",
                "value": 0
            },
            {
                "id": "7",
                "measure": "electronicBids",
                "relatedLot": "1",
                "value": 2
            },
            {
                "id": "14",
                "measure": "electronicBids",
                "relatedLot": "3",
                "value": 2
            },
            {
                "id": "21",
                "measure": "electronicBids",
                "relatedLot": "4",
                "value": 2
            },
            {
                "id": "28",
                "measure": "electronicBids",
                "relatedLot": "5",
                "value": 2
            },
            {
                "id": "1",
                "measure": "lowestValidBidValue",
                "relatedLot": "1",
                "value": 1,
                "currency": "GBP"
            },
            {
                "id": "8",
                "measure": "lowestValidBidValue",
                "relatedLot": "3",
                "value": 1,
                "currency": "GBP"
            },
            {
                "id": "15",
                "measure": "lowestValidBidValue",
                "relatedLot": "4",
                "value": 1,
                "currency": "GBP"
            },
            {
                "id": "22",
                "measure": "lowestValidBidValue",
                "relatedLot": "5",
                "value": 1,
                "currency": "GBP"
            },
            {
                "id": "2",
                "measure": "highestValidBidValue",
                "relatedLot": "1",
                "value": 1,
                "currency": "GBP"
            },
            {
                "id": "9",
                "measure": "highestValidBidValue",
                "relatedLot": "3",
                "value": 1,
                "currency": "GBP"
            },
            {
                "id": "16",
                "measure": "highestValidBidValue",
                "relatedLot": "4",
                "value": 1,
                "currency": "GBP"
            },
            {
                "id": "23",
                "measure": "highestValidBidValue",
                "relatedLot": "5",
                "value": 1,
                "currency": "GBP"
            }
        ]
    }
}